J. Biol. Chem., Vol. 265, Issue 23, 13635-13640, Aug, 1990

Post-transcriptional regulation of cAMP-dependent protein kinase activity by cAMP in GH3 pituitary tumor cells. Evidence for increased degradation of catalytic subunit in the presence of cAMP

JM Richardson, P Howard, JS Massa and RA Maurer
Department of Physiology and Biophysics, University of Iowa, Iowa City 52242.

The effects of cyclic AMP treatment on total cAMP-dependent protein kinase activity in GH3 pituitary tumor cells have been studied. Incubation of cells for 24 h with 1 microM forskolin resulted in a 50% decrease in total cAMP-dependent protein kinase activity which was reversible upon removal of forskolin from culture media. A similar response was observed in GH3 cells treated with 5 ng/ml cholera toxin and 0.5 mM dibutyryl cAMP but not 0.5 mM dibutyryl cGMP. Northern blot analysis demonstrated that the steady-state level of the mRNA for each of the six kinase subunit isoforms studied was not detectably altered after treatment with 1 microM forskolin for 24 h. The concentration of catalytic subunit was also assessed by binding studies using a radiolabeled heat-stable protein kinase inhibitor. Treatment of GH3 cells with 1 microM forskolin for 24 h reduced protein kinase inhibitor binding activity by 50%, consistent with the observed forskolin-induced decrease in total kinase activity. Analysis of endogenous heat-stable protein kinase inhibitor activity in GH3 cell extracts showed no significant difference between forskolin-treated cells and cells maintained under control conditions. To assess possible effects on catalytic subunit degradation, pulse-chase experiments were performed and radiolabeled catalytic subunit was isolated by affinity chromatography. The results demonstrated that treatment of cells with chlorophenylthio-cAMP detectably increased the apparent degradation of radiolabeled catalytic subunit. The increased degradation of the catalytic subunit was sufficient to account for the observed decreases in kinase activity. These results suggest that relatively long term cAMP treatment can alter total cAMP-dependent protein kinase activity through effects to alter the degradation of the catalytic subunit of the enzyme.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. A. Burton, D. A. McDermott, D. Wilkes, M. N. Poulsen, M. A. Nolan, M. Goldstein, C. T. Basson, and G. S. McKnight Haploinsufficiency at the Protein Kinase A RI{alpha} Gene Locus Leads to Fertility Defects in Male Mice and Men Mol. Endocrinol., October 1, 2006; 20(10): 2504 - 2513. [Abstract] [Full Text] [PDF]

				M. B. Maron, H. G. Folkesson, S. M. Stader, and J. M. Walro PKA delivery to the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced alveolar epithelial PKA desensitization Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L349 - L354. [Abstract] [Full Text] [PDF]

				E C Chin, T E Harris, and D R E Abayasekara Changes in cAMP-dependent protein kinase (PKA) and progesterone secretion in luteinizing human granulosa cells J. Endocrinol., October 1, 2004; 183(1): 39 - 50. [Abstract] [Full Text] [PDF]

				E. E. Morgan, S. M. Stader, C. M. Hodnichak, K. E. Mavrich, H. G. Folkesson, and M. B. Maron Postreceptor defects in alveolar epithelial {beta}-adrenergic signaling after prolonged isoproterenol infusion Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L578 - L583. [Abstract] [Full Text] [PDF]

				K. W. Cheng and P. C. K. Leung Human Chorionic Gonadotropin-Activated cAMP Pathway Regulates Human Placental GnRH Receptor Gene Transcription in Choriocarcinoma JEG-3 Cells J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3291 - 3299. [Abstract] [Full Text] [PDF]

				X.-b. Han and P. M. Conn The Role of Protein Kinases A and C Pathways in the Regulation of Mitogen-Activated Protein Kinase Activation in Response to Gonadotropin-Releasing Hormone Receptor Activation Endocrinology, May 1, 1999; 140(5): 2241 - 2251. [Abstract] [Full Text]

				X. Cheng, Y. Ma, M. Moore, B. A. Hemmings, and S. S. Taylor Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase PNAS, August 18, 1998; 95(17): 9849 - 9854. [Abstract] [Full Text] [PDF]

				V. A. Boundy, J. Chen, and E. J. Nestler Regulation of cAMP-Dependent Protein Kinase Subunit Expression in CATH.a and SH-SY5Y Cells J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 1058 - 1065. [Abstract] [Full Text]

				R. Telgmann, E. Maronde, K. Tasken, and B. Gellersen Activated Protein Kinase A Is Required for Differentiation-Dependent Transcription of the Decidual Prolactin Gene in Human Endometrial Stromal Cells Endocrinology, March 1, 1997; 138(3): 929 - 937. [Abstract] [Full Text] [PDF]

				J. Lew, N. Coruh, I. Tsigelny, S. Garrod, and S. S. Taylor Synergistic Binding of Nucleotides and Inhibitors to cAMP-dependent Protein Kinase Examined by Acrylodan Fluorescence Spectroscopy J. Biol. Chem., January 17, 1997; 272(3): 1507 - 1513. [Abstract] [Full Text] [PDF]

				S.-L. Lee and R. A. Steinberg Pathways for Degradation of the Catalytic Subunit of cAMP-dependent Protein Kinase Differ in Wild-type and Kinase-negative S49 Mouse Lymphoma Cells J. Biol. Chem., July 12, 1996; 271(28): 16553 - 16558. [Abstract] [Full Text] [PDF]